How Will EV, Pembrolizumab Combination Change the Bladder Cancer Treatment Landscape?
18:36
Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr.Tom Powles
26:20
Management of Non-Muscle Invasive Bladder Cancer
6:06
Treatment Options for Patients Not Eligible for the EV/Pembrolizumab Regimen
50:55
Live from AUA2024: Highlights in Bladder Cancer
23:56
Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand
19:47
Zayıflayamayan kadınlar ne yapmalı? Oytun Erbaş açıklıyor...
11:29
Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles, MD
37:50